Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.50 |
| ▸ | POLRMT | O00411 | 1/20 | 0.32 |
| ▸ | RIPK1 | Q13546 | 3/20 | 0.31 |
| ▸ | DOT1L | Q8TEK3 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31473192 | 0.87 | TMPRSS2 (0.53) | TMPRSS2POLRMTRIPK1DOT1L | |
| SCHEMBL30939839 | 0.86 | TMPRSS2 (0.46) | TMPRSS2POLRMTRIPK1 | |
| SCHEMBL20533524 | 0.85 | TMPRSS2 (0.53) | TMPRSS2POLRMT | |
| SCHEMBL25909499 | 0.85 | TMPRSS2 (0.51) | TMPRSS2POLRMT | |
| SCHEMBL26094319 | 0.85 | TMPRSS2 (0.51) | TMPRSS2POLRMTRIPK1DOT1L | |
| SCHEMBL30939807 | 0.85 | TMPRSS2 (0.44) | TMPRSS2POLRMT | |
| SCHEMBL23960046 | 0.85 | TMPRSS2 (0.48) | TMPRSS2POLRMTRIPK1 | |
| Gs-441524 SCHEMBL23870459 | 0.84 | TMPRSS2 (0.60) | TMPRSS2POLRMT | |
| Gs-441524 SCHEMBL22142944 | 0.84 | TMPRSS2 (0.60) | TMPRSS2POLRMT | |
| Gs-441524 SCHEMBL24667691 | 0.84 | TMPRSS2 (0.60) | TMPRSS2POLRMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118304315-B | Application of nucleoside compound in preparation of respiratory syncytial virus infection resistant related products | 深圳安泰维生物医药有限公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-117599063-B | Application of nucleoside compound in preparation of poxvirus related products | 深圳安泰维生物医药有限公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-118304315-A | Application of nucleoside compound in preparation of respiratory syncytial virus infection resistant related products | 深圳安泰维生物医药有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-118027040-A | Nucleoside compound for treating coronavirus infection and application thereof | 南方科技大学 | 2024-05-14 | — | — | CN | disclosed |
| CN-117964624-A | Nucleoside compound with effect of treating viral infection and application thereof | 南方科技大学 | 2024-05-03 | — | — | CN | disclosed |
| CN-117777141-A | Nucleoside compound for resisting virus infection and application thereof | 南方科技大学 | 2024-03-29 | — | — | CN | disclosed |
| CN-117599063-A | Application of nucleoside compound in preparation of poxvirus related products | 深圳安泰维生物医药有限公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-116370479-B | Use of compound ATV014 in the preparation of a product for the treatment of novel coronavirus infection | 南方科技大学 | 2024-02-13 | — | — | CN | disclosed |
| CN-113735862-B | Nucleoside compound for treating viral infection and application thereof | 南方科技大学 | 2024-02-02 | — | — | CN | disclosed |
| CN-116874490-A | Compound ATV014 or pharmaceutically acceptable salts thereof and pharmaceutical compositions thereof | 南方科技大学 | 2023-10-13 | — | — | CN | disclosed |
| CN-116370479-A | Use of compound ATV014 in the preparation of a product for the treatment of novel coronavirus infection | 南方科技大学 | 2023-07-04 | — | — | CN | disclosed |